SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $122 | -99.9% | 21,840 | -38.5% | 0.00% | – |
Q3 2022 | $228,000 | -87.7% | 35,488 | -93.5% | 0.00% | -100.0% |
Q2 2022 | $1,861,000 | -44.2% | 542,755 | +15.9% | 0.00% | 0.0% |
Q1 2022 | $3,334,000 | +481.8% | 468,311 | +1211.8% | 0.00% | – |
Q3 2017 | $573,000 | +38.4% | 35,700 | -2.5% | 0.00% | – |
Q2 2017 | $414,000 | +46.3% | 36,600 | +45.7% | 0.00% | – |
Q1 2017 | $283,000 | – | 25,112 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $110,730,646 | 4.94% |
Lion Point Capital, LP | 691,803 | $3,313,736 | 1.50% |
Eversept Partners, LP | 3,076,756 | $14,737,661 | 1.23% |
Soleus Capital Management, L.P. | 2,045,983 | $9,800,259 | 1.09% |
Knott David M Jr | 470,000 | $2,251 | 0.90% |
GREAT POINT PARTNERS LLC | 938,067 | $4,493,341 | 0.88% |
Simplify Asset Management Inc. | 550,626 | $2,637,499 | 0.35% |
Delphia (USA) Inc. | 33,913 | $162,443 | 0.26% |
Alpha DNA Investment Management LLC | 138,536 | $663,587 | 0.22% |
Avoro Capital Advisors LLC | 2,500,000 | $11,975,000 | 0.16% |